Skip to Content

EP 107 (Acetazolamide Extended Release 500 mg)

Pill with imprint EP 107 is Orange & White, Capsule-shape and has been identified as Acetazolamide Extended Release 500 mg. It is supplied by Zydus Pharmaceuticals.

Acetazolamide is used in the treatment of glaucoma; hydrocephalus; edema; epilepsy; mountain sickness / altitude sickness and belongs to the drug classes carbonic anhydrase inhibitor anticonvulsants, carbonic anhydrase inhibitors. Risk cannot be ruled out during pregnancy. Acetazolamide 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for EP 107

Acetazolamide Extended Release

Imprint
EP 107
Strength
500 mg
Color
Orange & White
Size
25.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants, Carbonic anhydrase inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals
Inactive Ingredients
ammonio methacrylate copolymer type A, ammonio methacrylate copolymer type B, FD&C Yellow No. 6, gelatin, microcrystalline cellulose, sodium lauryl sulfate, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
68382-0261 Zydus Pharmaceuticals (USA) Inc.
68084-0401 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.